45 related articles for article (PubMed ID: 18774544)
1. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Transl Res; 2008 Sep; 152(3):143-9. PubMed ID: 18774544
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Cancer and Fibroblasts.
Avagliano A; Fiume G; Bellevicine C; Troncone G; Venuta A; Acampora V; De Lella S; Ruocco MR; Masone S; Velotti N; Carotenuto P; Mallardo M; Caiazza C; Montagnani S; Arcucci A
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077709
[TBL] [Abstract][Full Text] [Related]
3. Impact of Epithelial-Mesenchymal Immunophenotype on Local Aggressiveness in Papillary Thyroid Carcinoma Invading the Airway.
Mandarano M; Andolfi M; Colella R; Monacelli M; Polistena A; Moretti S; Bellezza G; Puxeddu E; Sanguinetti A; Sidoni A; Avenia N; Puma F; Vannucci J
J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640369
[TBL] [Abstract][Full Text] [Related]
4. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
Kim HS; Kim HJ; Lee MR; Han I
BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical basigin expression level in thyroid cancer tissues.
Guo WP; Tang D; Pang YY; Li XJ; Chen G; Huang ZG; Tang XZ; Lai QQ; Gan JY; Huang XL; Liu XF; Wei ZX; Ma W
World J Surg Oncol; 2020 Sep; 18(1):240. PubMed ID: 32891152
[TBL] [Abstract][Full Text] [Related]
6. Thyroid tumor cells-fibroblasts crosstalk: role of extracellular vesicles.
Bravo-Miana RDC; Della Vedova AB; De Paul AL; Remedi MM; Guantay ML; Gilardoni MB; Pellizas CG; Donadio AC
Endocr Connect; 2020 Jun; 9(6):506-518. PubMed ID: 32485677
[TBL] [Abstract][Full Text] [Related]
7. CD147 expression was positively linked to aggressiveness and worse prognosis of gastric cancer: a meta and bioinformatics analysis.
Zheng HC; Gong BC
Oncotarget; 2017 Oct; 8(52):90358-90370. PubMed ID: 29163835
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies.
Fan H; Yi W; Wang C; Wang J
Oncotarget; 2017 Oct; 8(47):82643-82660. PubMed ID: 29137291
[TBL] [Abstract][Full Text] [Related]
9. iTRAQ-coupled 2D LC/MS-MS analysis of CXCR7-transfected papillary thyroid carcinoma cells: A new insight into CXCR7 regulation of papillary thyroid carcinoma progression and identification of potential biomarkers.
Zhang H; Yang L; Liu Z; Liu C; Teng X; Zhang L; Yin B; Liu Z
Oncol Lett; 2017 Sep; 14(3):3734-3740. PubMed ID: 28927140
[TBL] [Abstract][Full Text] [Related]
10. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients.
Liu S; Tian Z; Zhang L; Hou S; Hu S; Wu J; Jing Y; Sun H; Yu F; Zhao L; Wang R; Tseng HR; Zhau HE; Chung LW; Wu K; Wang H; Wu JB; Nie Y; Shao C
Oncotarget; 2016 Sep; 7(37):59877-59891. PubMed ID: 27494883
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer.
Yuan Y; Shen N; Yang SY; Zhao L; Guan YM
Oncol Lett; 2015 Jul; 10(1):342-348. PubMed ID: 26171027
[TBL] [Abstract][Full Text] [Related]
13. Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique.
Tang T; Zhang DL
Exp Ther Med; 2015 Apr; 9(4):1331-1335. PubMed ID: 25780431
[TBL] [Abstract][Full Text] [Related]
14. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
15. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
Sato M; Nakai Y; Nakata W; Yoshida T; Hatano K; Kawashima A; Fujita K; Uemura M; Takayama H; Nonomura N
PLoS One; 2013; 8(9):e74313. PubMed ID: 24073208
[TBL] [Abstract][Full Text] [Related]
16. The role of EMMPRIN expression in ovarian epithelial carcinomas.
Zhao Y; Chen S; Gou WF; Niu ZF; Zhao S; Xiao LJ; Takano Y; Zheng HC
Cell Cycle; 2013 Sep; 12(17):2899-913. PubMed ID: 23966157
[TBL] [Abstract][Full Text] [Related]
17. Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer.
Zhao SH; Wang Y; Wen L; Zhai ZB; Ai ZH; Yao NL; Wang L; Liu WC; Chen BL; Li Y; Yang H
J Transl Med; 2013 Apr; 11():92. PubMed ID: 23566400
[TBL] [Abstract][Full Text] [Related]
18. Role of emmprin in endometrial cancer.
Nakamura K; Kodama J; Hongo A; Hiramatsu Y
BMC Cancer; 2012 May; 12():191. PubMed ID: 22640183
[TBL] [Abstract][Full Text] [Related]
19. Baculovirus display of single chain antibody (scFv) using a novel signal peptide.
Kitidee K; Nangola S; Gonzalez G; Boulanger P; Tayapiwatana C; Hong SS
BMC Biotechnol; 2010 Nov; 10():80. PubMed ID: 21092083
[TBL] [Abstract][Full Text] [Related]
20. [EMMPRIN (CD147). A prognostic and potentially therapeutic marker in urothelial cancer].
Nawroth R; Hartmann A; Wild P; Lehmann J; Stöhr R; Gschwend JE; Retz M
Pathologe; 2010 Oct; 31 Suppl 2():251-4. PubMed ID: 20661575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
